Clinical Trials Directory

Trials / Completed

CompletedNCT00976053

Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging

Clinical Effectiveness of Pharmacologic Stress Radionuclide Myocardial Perfusion Imaging as a Guide to Management of Patients With Known CAD: Comparison of Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
330 (actual)
Sponsor
Aspire Foundation · Academic / Other
Sex
All
Age
30 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare pharmacologic stress myocardial perfusion PET with pharmacologic stress myocardial perfusion SPECT in a near-simultaneous, head-to-head comparison in the same patient. The investigators hypothesize that pharmacologic stress myocardial perfusion PET will prove superior to pharmacologic stress myocardial perfusion SPECT as a first-line diagnostic test for higher-risk patients with known coronary artery disease (CAD) who present with symptoms consistent with possible worsening of their CAD.

Conditions

Interventions

TypeNameDescription
PROCEDUREMyocardial perfusion imagingRandomization assignment to one of SPECT or PET myocardial perfusion imaging

Timeline

Start date
2009-06-01
Primary completion
2013-09-01
Completion
2014-10-01
First posted
2009-09-14
Last updated
2014-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00976053. Inclusion in this directory is not an endorsement.